Nanobiotix Stock Analysis

Nanobiotix Stock Analysis Notes

The company recorded a loss per share of 1.67. Nanobiotix had not issued any dividends in recent years. Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. The company was incorporated in 2003 and is headquartered in Paris, France. Nanobiotix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 103 people. To find out more about Nanobiotix contact the company at 33 1 40 26 04 70 or learn more at https://www.nanobiotix.com.

Nanobiotix Investment Alerts

Nanobiotix Upcoming and Recent Events

Nanobiotix Largest EPS Surprises

View All Earnings Estimates

Nanobiotix Environmental, Social, and Governance (ESG) Scores

Nanobiotix Stock Institutional Investors

Note, although Nanobiotix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nanobiotix Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 241.29 M.

Nanobiotix Profitablity

Management Efficiency

Nanobiotix has return on total asset (ROA) of (0.5289) % which means that it has lost $0.5289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9869) %, meaning that it created substantial loss on money invested by shareholders. Nanobiotix's management efficiency ratios could be used to measure how well Nanobiotix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 1.90 in 2025, whereas Return On Tangible Assets are likely to drop (1.06) in 2025. At this time, Nanobiotix's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 5.3 M in 2025, whereas Total Assets are likely to drop slightly above 57.8 M in 2025.

Technical Drivers

As of the 23rd of July, Nanobiotix secures the Mean Deviation of 3.38, downside deviation of 3.79, and Risk Adjusted Performance of 0.1604. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nanobiotix, as well as the relationship between them.

Nanobiotix Price Movement Analysis

Nanobiotix Outstanding Bonds

Nanobiotix Predictive Daily Indicators

Nanobiotix Corporate Filings

Nanobiotix Forecast Models

Nanobiotix's time-series forecasting models are one of many Nanobiotix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nanobiotix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nanobiotix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nanobiotix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nanobiotix. By using and applying Nanobiotix Stock analysis, traders can create a robust methodology for identifying Nanobiotix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nanobiotix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nanobiotix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Nanobiotix stock analysis indicators help investors evaluate how Nanobiotix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nanobiotix shares will generate the highest return on investment. By understating and applying Nanobiotix stock analysis, traders can identify Nanobiotix position entry and exit signals to maximize returns.

When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.